181 related articles for article (PubMed ID: 33650661)
21. NOTCH3 promotes docetaxel resistance of prostate cancer cells through regulating TUBB3 and MAPK signaling pathway.
Sun X; Zhang Y; Xin S; Jin L; Cao Q; Wang H; Wang K; Liu X; Tang C; Li W; Li Z; Wen X; Yang G; Guo C; Liu Z; Ye L
Cancer Sci; 2024 Feb; 115(2):412-426. PubMed ID: 38115797
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-145 inhibits lung cancer cell metastasis.
Ling DJ; Chen ZS; Zhang YD; Liao QD; Feng JX; Zhang XY; Shi TS
Mol Med Rep; 2015 Apr; 11(4):3108-14. PubMed ID: 25483817
[TBL] [Abstract][Full Text] [Related]
23. MiR-129-5p promotes docetaxel resistance in prostate cancer by down-regulating CAMK2N1 expression.
Wu C; Miao C; Tang Q; Zhou X; Xi P; Chang P; Hua L; Ni H
J Cell Mol Med; 2020 Feb; 24(3):2098-2108. PubMed ID: 31876385
[TBL] [Abstract][Full Text] [Related]
24. Suppression of hepatitis B virus core promoter by the nuclear orphan receptor TR4.
Lin WJ; Li J; Lee YF; Yeh SD; Altuwaijri S; Ou JH; Chang C
J Biol Chem; 2003 Mar; 278(11):9353-60. PubMed ID: 12522137
[TBL] [Abstract][Full Text] [Related]
25. Testicular orphan receptor 4 promotes tumor progression and implies poor survival through AKT3 regulation in seminoma.
Chen Y; Lu J; Xia L; Xue D; Yu X; Shen D; Xu L; Li G
Cancer Sci; 2018 Feb; 109(2):384-394. PubMed ID: 29197138
[TBL] [Abstract][Full Text] [Related]
26. Circ_0004087 interaction with SND1 promotes docetaxel resistance in prostate cancer by boosting the mitosis error correction mechanism.
Chen L; Song Y; Hou T; Li X; Cheng L; Li Y; Xing Y
J Exp Clin Cancer Res; 2022 Jun; 41(1):194. PubMed ID: 35659274
[TBL] [Abstract][Full Text] [Related]
27. miR-27b and miR-34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1.
Zhang G; Tian X; Li Y; Wang Z; Li X; Zhu C
Biomed Pharmacother; 2018 Jan; 97():736-744. PubMed ID: 29102917
[TBL] [Abstract][Full Text] [Related]
28. Protein Disulfide Isomerase 4 Drives Docetaxel Resistance in Prostate Cancer.
Qian S; Zhang S; Wu Y; Ding Y; ; Li X
Chemotherapy; 2020; 65(5-6):125-133. PubMed ID: 33238278
[TBL] [Abstract][Full Text] [Related]
29. The role of testicular nuclear receptor 4 in chemo-resistance of docetaxel in castration-resistant prostate cancer.
Chen B; Yu S; Ding X; Jing C; Xia L; Wang M; Matro E; Rehman F; Niu Y; Li G; Chang C
Cancer Gene Ther; 2014 Oct; 21(10):411-5. PubMed ID: 25104727
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI.
Yang YP; Chien Y; Chiou GY; Cherng JY; Wang ML; Lo WL; Chang YL; Huang PI; Chen YW; Shih YH; Chen MT; Chiou SH
Biomaterials; 2012 Feb; 33(5):1462-76. PubMed ID: 22098779
[TBL] [Abstract][Full Text] [Related]
32. Metformin inhibits nuclear receptor TR4-mediated hepatic stearoyl-CoA desaturase 1 gene expression with altered insulin sensitivity.
Kim E; Liu NC; Yu IC; Lin HY; Lee YF; Sparks JD; Chen LM; Chang C
Diabetes; 2011 May; 60(5):1493-503. PubMed ID: 21478464
[TBL] [Abstract][Full Text] [Related]
33. Reduction of circular RNA Foxo3 promotes prostate cancer progression and chemoresistance to docetaxel.
Shen Z; Zhou L; Zhang C; Xu J
Cancer Lett; 2020 Jan; 468():88-101. PubMed ID: 31593800
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic activation of METTL14 promotes docetaxel resistance in prostate cancer by promoting pri-microRNA-129 maturation.
Wu C; Miao C; Zhou S; Chang PA; He B; Zhou X; Tang Q
Environ Toxicol; 2024 Jun; 39(6):3734-3745. PubMed ID: 38546343
[TBL] [Abstract][Full Text] [Related]
35. OCT4 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells by miR-125b/BAK1 pathway.
Wang YD; Cai N; Wu XL; Cao HZ; Xie LL; Zheng PS
Cell Death Dis; 2013 Aug; 4(8):e760. PubMed ID: 23928699
[TBL] [Abstract][Full Text] [Related]
36. Exosomal Circ-XIAP Promotes Docetaxel Resistance in Prostate Cancer by Regulating miR-1182/TPD52 Axis.
Zhang H; Li M; Zhang J; Shen Y; Gui Q
Drug Des Devel Ther; 2021; 15():1835-1849. PubMed ID: 33976535
[TBL] [Abstract][Full Text] [Related]
37. LncRNA LINC00184 promotes docetaxel resistance and immune escape via miR-105-5p/PD-L1 axis in prostate cancer.
Zhang W; Xin J; Lai J; Zhang W
Immunobiology; 2022 Jan; 227(1):152163. PubMed ID: 34896914
[TBL] [Abstract][Full Text] [Related]
38. Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer.
Kroon J; Puhr M; Buijs JT; van der Horst G; Hemmer DM; Marijt KA; Hwang MS; Masood M; Grimm S; Storm G; Metselaar JM; Meijer OC; Culig Z; van der Pluijm G
Endocr Relat Cancer; 2016 Jan; 23(1):35-45. PubMed ID: 26483423
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer.
Chen C; Cai Z; Zhuo Y; Xi M; Lin Z; Jiang F; Liu Z; Wan Y; Zheng Y; Li J; Zhou X; Zhu J; Zhong W
BMC Cancer; 2020 Apr; 20(1):289. PubMed ID: 32252682
[TBL] [Abstract][Full Text] [Related]
40. Acetyl-11-keto-β-boswellic acid suppresses docetaxel-resistant prostate cancer cells in vitro and in vivo by blocking Akt and Stat3 signaling, thus suppressing chemoresistant stem cell-like properties.
Liu YQ; Wang SK; Xu QQ; Yuan HQ; Guo YX; Wang Q; Kong F; Lin ZM; Sun DQ; Wang RM; Lou HX
Acta Pharmacol Sin; 2019 May; 40(5):689-698. PubMed ID: 30171201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]